This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Co-inhibition of HDAC and MLL-menin interaction targets MLL-rearranged acute myeloid leukemia cells via disruption of DNA damage checkpoint and DNA repair
Clinical Epigenetics Open Access 07 October 2019
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Sheridan, C. First new drug approval for AML in 15 years. Nat Biotechnol 35, 696–698 (2017). https://doi.org/10.1038/nbt0817-696
Published:
Issue Date:
DOI: https://doi.org/10.1038/nbt0817-696